Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor.
暂无分享,去创建一个
B. Zauscher | V. Nosé | M. Puder | I. Alwayn | Charlotte Andersson | Vânia Nosé | K. Gura | Ian P J Alwayn | Blanca Zauscher | Kathleen Gura | Mark Puder | C. Andersson
[1] D. Cooper,et al. Xenotransplantation--how far have we come? , 2002, Transplant immunology.
[2] Karl G Sylvester,et al. Stem cells: review and update. , 2004, Archives of surgery.
[3] G. Klintmalm,et al. THE USE OF mARGINAL DONORS FOR LIVER TRANSPLANTATION A RETROSPECTIVE STUDY OF 365 LIVER DONORS 1,2 , 1992, Transplantation.
[4] W. Jochum,et al. Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. , 2003, Journal of Hepatology.
[5] P. Mcmaster,et al. Policies in Europe on "marginal quality" donor livers , 1994, The Lancet.
[6] R. Tompkins,et al. Technique for expanding the donor liver pool: Heat shock preconditioning in a rat fatty liver model , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[7] J. Clore,et al. Dietary n‐3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats , 2004, Hepatology.
[8] S. Kitano,et al. ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1 , 2001, Transplantation.
[9] R. Busuttil,et al. The utility of marginal donors in liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[10] S. Fan,et al. Safety of donors in live donor liver transplantation using right lobe grafts. , 2000, Archives of surgery.
[11] Michael J Lysaght,et al. Tissue engineering: the end of the beginning. , 2004, Tissue engineering.
[12] A. Burke,et al. Non‐Alcoholic Fatty Liver Disease, Non‐Alcoholic Steatohepatitis and Orthotopic Liver Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] R. Stratta,et al. FROZEN SECTION EVALUATION OF DONOR LIVERS BEFORE TRANSPLANTATION , 1993, Transplantation.
[14] V. Nosé,et al. Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB‐1 suppression or by correcting essential fatty acid deficiency , 2004, Hepatology.
[15] K. Sugimachi,et al. Use of steatotic graft in living-donor liver transplantation , 2003, Transplantation.
[16] T. Fishbein,et al. Use of livers with microvesicular fat safely expands the donor pool. , 1997, Transplantation.
[17] Zhaoli Sun,et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. , 2003, Gastroenterology.
[18] J. Alvarez,et al. Separation of acidic and neutral lipids by aminopropyl-bonded silica gel column chromatography. , 1992, Journal of chromatography.
[19] T E Starzl,et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. , 1989, Transplantation.